银谷制药有限责任公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
5
NMPA:5
Drug Approvals
Ambroxol Hydrochloride Solution for Inhalation
- Product Name
- 吸入用盐酸氨溴索溶液
- Approval Number
- 国药准字H20223050
- Approval Date
- Jan 30, 2022
NMPA
Calcitonin(Salmon) Injection
- Product Name
- 鲑降钙素注射液
- Approval Number
- 国药准字H20070084
- Approval Date
- Dec 7, 2020
NMPA
Calcitonin(Salmon) Nasal Spray
- Product Name
- 金尔力
- Approval Number
- 国药准字H20030905
- Approval Date
- Jun 23, 2020
NMPA
Bencycloquidium Bromide Nasal Spray
- Product Name
- 必立汀
- Approval Number
- 国药准字H20200003
- Approval Date
- Mar 17, 2020
NMPA
Clinical Trials
No trials found
News
No news found